Temporary injection-site pain, redness, warmth, nausea, dizziness, headache, or rash may occur
However it can be argued that the key should be to prevent non diabetic hyperglycaemia state developing into full blown diabetes, which is often associated with multiple complications
A phase II trial focusing on individuals with overweight or obesity, coupled with hypertension or dyslipidemia but without T2D, found that cagrilintide (2.4 mg) alongside diet and exercise, led to a 10% body weight reduction compared to 3% with placebo over 26 weeks [99]
DOI: 10.1183/13993003.00161-2019 [Google Scholar] Garvey WT, Batterham RL, Bhatta M, Buscemi S, Christensen LN, Frias JP, et al
A full-blown boom